Kerwood Capital Partners, LLC

About The Fund

Kerwood Capital Partners, commonly known by their website name Torrey Pines Investment, is a venture capital fund that specializes in the life sciences sector. Founded in 2012 and located at 12760 High Bluff Drive, Suite 370, San Diego, California, their firm is deeply entrenched in nurturing and advancing the field of biotechnology with a keen focus on therapeutic areas such as CNS disorders, oncology, and virology. Torrey Pines Investment takes pride in their team of professionals who bring a wealth of experience in entrepreneurship, venture capital, as well as operational expertise necessary to drive portfolio companies towards success. They have supported biopharma and diagnostics accelerators, actively investing in early development stage assets from pharmaceutical and biotech partners. Their investment thesis revolves around bringing these early stage developments to fruition through strategic partnerships with pharmaceutical companies and merger and acquisition opportunities. Their portfolio is inclusive of companies like Viriom Inc., Avelas Biosciences, and Chromis Therapeutics, each involved in groundbreaking work in their respective fields, from curing HIV and chronic HBV to revolutionizing cancer surgery. Other notable inclusions are i2020 Accelerator, Leap Therapeutics, Afraxis, Vaxxas, and Context Therapeutics, showcasing a diverse range within the biotech domain. The firm provides comprehensive support to its portfolio companies, engaging their expertise in drug discovery, non-clinical and clinical studies, manufacturing, quality control, and regulatory affairs to craft a path toward growth, value building, and wealth realization. The leadership team, including Founding President Ronald Demuth and Managing Member Nikolay Savchuk, reflects the firm's commitment to innovation and success in the life sciences investment landscape.